AEM vs CPAC

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

CPAC presents a stable Piotroski F-Score of 6/9, but this is overshadowed by severe valuation and liquidity concerns. The stock is trading at a significant premium to both its Graham Number ($6.75) and Intrinsic Value ($3.57), while the forward P/E of 69.48 suggests a projected collapse in earnings. Most alarming are the unsustainable dividend payout ratio of 115.75% and a critical quick ratio of 0.22, indicating a potential liquidity crisis. Despite strong historical price action, the current technical trend is heavily bearish (10/100).